Original language | English |
---|---|
Pages (from-to) | 474-485 |
Number of pages | 12 |
Journal | The Lancet Oncology |
Volume | 19 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2018 |
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
Sabino De Placido, Ciro Gallo, Michelino De Laurentiis, Giancarlo Bisagni, Grazia Arpino, Maria Giuseppa Sarobba, Ferdinando Riccardi, Antonio Russo, Lucia Del Mastro, Francesco Cognetti, Filippo Montemurro, Antonio Bernardo, Adriano Gravina, Francesco Nuzzo, Francesco Perrone
Research output: Contribution to journal › Article › peer-review